A new test measuring skin cholesterol provides a non-invasive, easy solution for patients who put off having bloodwork done. The PreVu Point of Care (POC) test identifies individuals who may be at a higher, hidden risk of coronary artery disease.
The POC test may become a tool in the prevention of the critical first incident; patients whose scores are elevated in the POC test will be advised to seek advice from their physician. The test will be made available across Canada in 2013, and Vancouverites are among the first to get their skin cholesterol tested by pharmacists.
Dr John Mancini, PreVu’s medical advisory board chair and a cardiologist at the University of British Columbia Vancouver Coastal Health Research Institute, endorses skin cholesterol testing, saying that this new biomarker can aid in the early detection of coronary artery disease risk. For more information visit www.prevu.com.